[{"trial_metadata": {"citation": "Journal of Hepatology, October 2023, vol. 79, 888\u2013897", "drug_name": "Efinopegdutide", "phase": "IIa", "indication": "Non-alcoholic fatty liver disease (NAFLD)", "numeric_trial_duration": 24, "trial_duration": "24 weeks", "safety_population_definition": "All randomized participants who received at least one dose of study intervention.", "NCT Number": "NCT04944992", "Sponsor": "Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.", "route of adminstration": "Subcutaneous"}, "baseline_table": [{"variable_label": "Sex: Male", "variable_label_raw": "Male", "categorical_label": "Sex", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 72, "arm_label": "Efinopegdutide", "arm_role": "treatment", "n": 39, "percent": 54.2, "mean": 0, "sd": 0, "raw_value": "39 (54.2)"}}, {"variable_label": "Sex: Female", "variable_label_raw": "Female", "categorical_label": "Sex", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 72, "arm_label": "Efinopegdutide", "arm_role": "treatment", "n": 33, "percent": 45.8, "mean": 0, "sd": 0, "raw_value": "33 (45.8)"}}, {"variable_label": "Age", "variable_label_raw": "Age, years", "categorical_label": "", "variable_type": "continuous", "units": "years", "arm_result": {"total_n": 72, "arm_label": "Efinopegdutide", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 48.1, "sd": 11.0, "raw_value": "48.1 [11.0]"}}], "ae_events": [{"AE_label_raw": "Adverse events", "event_category": "Adverse events", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 64, "percent_with_event": 88.9}}, {"AE_label_raw": "Drug-related adverse events", "event_category": "Drug-related adverse events", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 46, "percent_with_event": 63.9}}, {"AE_label_raw": "Serious adverse events", "event_category": "Serious adverse events", "is_any_ae": false, "is_serious_ae": true, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 1, "percent_with_event": 1.4}}, {"AE_label_raw": "Serious drug-related adverse events", "event_category": "Serious drug-related adverse events", "is_any_ae": false, "is_serious_ae": true, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 0, "percent_with_event": 0}}, {"AE_label_raw": "Deaths", "event_category": "Deaths", "is_any_ae": false, "is_serious_ae": false, "is_fatal": true, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 0, "percent_with_event": 0}}, {"AE_label_raw": "Discontinued drug due to an adverse event", "event_category": "Discontinued drug due to an adverse event", "is_any_ae": false, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": true, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 4, "percent_with_event": 5.6}}, {"AE_label_raw": "Discontinued drug due to a drug-related adverse event", "event_category": "Discontinued drug due to a drug-related adverse event", "is_any_ae": false, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": true, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 3, "percent_with_event": 4.2}}, {"AE_label_raw": "Gastrointestinal adverse events: Abdominal pain", "event_category": "Gastrointestinal adverse events", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 9, "percent_with_event": 12.5}}, {"AE_label_raw": "Gastrointestinal adverse events: Constipation", "event_category": "Gastrointestinal adverse events", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 12, "percent_with_event": 16.7}}, {"AE_label_raw": "Gastrointestinal adverse events: Nausea", "event_category": "Gastrointestinal adverse events", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Efinopegdutide", "total_n": 72, "arm_role": "treatment", "n_with_event": 20, "percent_with_event": 27.8}}]}]